Document:

Document

Exhibit 10.4

October 7, 2022 

Via Email (to lucalazzaron@yahoo.it)

Luca Lazzaron
V. S. Leopoldo 1, 
Albignasego (PD) 
35020 Italy

Re: First Amendment to Transition, Separation and Release of Claims Agreement

Dear Luca: 

This First Amendment to the Transition, Separation and Release of Claims Agreement (the “Amendment”) is by and between you and Sprinklr Switzerland GmbH (“Sprinklr Switzerland”).

Whereas, you and Sprinklr Switzerland entered into a Transition, Separation and Release of Claims Agreement dated October 3, 2022 (the “Agreement”); 

Whereas, you and Sprinklr Switzerland desire to clarify and amend certain terms in the Agreement as set forth below; and

Whereas, Section 16 of the Agreement provides for the amendment of the Agreement in accordance with the terms set forth therein. 

Now, therefore, in consideration of the mutual representations and covenants contained in this Amendment, and subject to the conditions set forth herein, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.References.  All capitalized terms used but not defined in this Amendment shall have the same meaning as prescribed in the Agreement.

2.Amendment: Section 4(d) of the Agreement is hereby deleted and replaced in its entirety as follows:
 
d.     Equity Awards and Vesting. You have been granted certain time-based vesting restricted stock units (“RSUs”), performance-based vesting restricted stock units (“PSUs”) and options to purchase shares of the Company’s Class A common stock (“Options” and together with the RSUs and PSUs, the “Equity Awards”), pursuant to the Company’s applicable equity incentive plan(s), Option agreements, PSU agreements or RSU agreements and other grant documents (collectively, the “Award Documents”).  Effective as of December 16, 2022 (the “Acceleration Date”) and as an additional Severance Benefit for you, the Company will accelerate the vesting of your Options and RSUs outstanding as of the Acceleration Date, such that the number of shares that would have vested in accordance with the applicable vesting schedule if you had continued providing service to the Company through and including June 30, 2023 will be deemed vested and, if applicable, exercisable (such options and time-vested restricted stock units, “Accelerated Equity”).  Notwithstanding the foregoing, in no event will the accelerated vesting result in you holding Accelerated Equity with intrinsic value in excess of $2.25 million as of the Acceleration Date (the “Maximum Value”), with such value to be calculated based on the closing price of the Company’s Class A common stock on the 

Acceleration Date.  Should the intrinsic value of your Accelerated Equity exceed the Maximum Value, the number of shares subject to the accelerated vesting will be reduced until the intrinsic value of the Accelerated Equity equals, as closely as possible, the Maximum Value, with the method of such reduction determined by the Company in its sole discretion.  Except as expressly set forth in this paragraph, the Equity Awards remain subject to the terms of the Award Documents. The Company shall use all reasonable efforts to promptly pre-clear any proposed transaction(s) in the Company’s securities, in accordance with the Company’s Insider Trading Policy, prior to the end of the Transition Period, assuming that the Company’s trading window is open at such time(s).

3.No Other Changes.  Upon signing, this Amendment is incorporated into the Agreement by reference herein, and except as expressly modified hereby, all other terms of the Agreement shall remain in full force and effect. 

In witness whereof, each of the parties has executed this Amendment as of the date set forth below. 

Sprinklr Switzerland GmbH                

_/s/ Daniel Haley___________                _10/7/22_______________
Daniel Haley                            Date
Managing Director

_/s/ Luca Lazzaron_______                    _10/7/22________________
Luca Lazzaron                        DateExhibit
10.1

 

CONFIDENTIAL
SEPARATION AGREEMENT AND GENERAL RELEASE AND WAIVER

 

1. This
Confidential Separation Agreement and General Release and Waiver (this “Agreement”) is made between Shawn M. Bowman
(“Employee”) and Sanara
MedTech Inc. (“Employer”)
(collectively the “Parties”
and each individually, a “Party”).

 

2. Employee
voluntarily resigned Employee’s position with Employer as President, Strategic Partnerships, resulting in Employee’s employment
with Employer ending effective December 2, 2022 (the “Termination Date”).
Employee agrees that Employee’s resignation of his position with Employer constituted
a resignation of all positions that Employee may have held with Employer or with any Released Party (as defined below) effective as of
the Termination Date, and Employee agrees to sign any additional documents that Employer may reasonably request to further document Employee’s
resignations.

 

3. Provided
that Employee (i) executes this Agreement, (ii) delivers this Agreement executed by Employee to Employer within twenty-two (22) days
of the Termination Date, and (iii) does not exercise the right of revocation referenced in Section 14(g) of this Agreement, Employer
shall:

 

(a) waive
all vesting requirements and forfeiture provisions of Employer’s 2014 Omnibus Long Term Incentive Plan (“LTIP”)
pertaining to Employee’s 4,519 shares of restricted common stock of Employer (“Shares”) granted to Employee
pursuant to the Restricted Stock Agreement between the Parties with a grant date of February 24, 2020 (the “RSA”),
all of which Shares shall be automatically fully vested, effective as of the Termination Date (the “Vesting Acceleration”);
and

 

(b) pay
Employee a lump-sum, cash payment equal to $60,000, less all applicable withholdings and deductions (the “Separation Payment”,
and together with the Vesting Acceleration referred to herein as, the “Separation Benefits”), payable on Employer’s
first regularly scheduled payroll date occurring after the expiration of the Revocation Period (as defined below).

 

Employee
acknowledges that Employee (i) is receiving the Separation Benefits outlined in this Section 3 in consideration for waiving Employee’s
right to claims released in Section 4, (ii) would not otherwise be entitled to the Separation Benefits referred to in this Section 3,
and (iii) is only owed the Separation Benefits referred to in this Section 3 in accordance with the terms of this Agreement.

 

4. In
exchange for the Separation Benefits set forth in Section 3, Employee, on behalf of Employee’s self and Employee’s
spouse, heirs, executors, trustees, administrators, representatives, and assigns, if any, hereby fully, finally, completely, and forever
releases, discharges, acquits, and relinquishes Employer and its parents, subsidiaries, affiliates, divisions, predecessors, successors,
and assigns, together with their present and former respective officers, directors, employees, shareholders, general partners, limited
partners, members, managers, owners, agents, representatives, attorneys and insurers (each of whom shall be referred to individually
as a “Released Party” and collectively as the “Released Parties”),
jointly and/or severally, from any and all claims, obligations, actions, demands, liabilities, and/or causes of action of whatever
kind or character, joint or several, whether known or unknown, suspected or unsuspected, asserted or unasserted, as a result of any and
all alleged acts, omissions, or events, arising in whole or in part prior to the execution of this Agreement by Employee, including,
without limitation, the following:

 

    	 

    	 

    

 

(i) any
claim under federal, state, or local law which provides civil remedies for the enforcement of rights arising out of the employment relationship,
including, without limitation, discrimination and retaliation claims, such as claims or causes of action under Title VII of the Civil
Rights Act of 1964, as amended, 42 U.S.C. § 2000 et seq.; The Civil Rights Act of 1866, as amended, 42 U.S.C. § 1981;
The Civil Rights Act of 1991, as amended, 42 U.S.C. § 1981a; the Age Discrimination in Employment Act 29 U.S.C. § 621 et
seq., Americans With Disabilities Act, as amended, 42 U.S.C. § 12101 et seq.; Fair Labor Standards Act, as amended, 29
U.S.C. § 201, et seq.; Employee Retirement Income Security Act, as amended, 29 U.S.C. § 1000 et seq.; Family
and Medical Leave Act, as amended, 29 U.S.C. § 2601, et seq.; the Texas Commission on Human Rights Act § 21.001 et seq.
of the Texas Labor Code, all as amended; or any other statute prohibiting discrimination or retaliation in employment under any federal,
state, or local law;

 

(ii) any
action under common law or in equity, including, but not limited to, claims based on alleged breach of an obligation or duty arising
in contract or tort, such as breach of contract, fraud, quantum meruit, wrongful discharge, defamation, infliction of emotional distress,
assault, battery, malicious prosecution, false imprisonment, harassment, negligence, gross negligence, and strict liability;

 

(iii) any
claim for lost, unpaid, or unequal wages, salary, stock options or any other benefits;

 

(iv) any
alleged unlawful act; and

 

(v) any
other claim regardless of the forum in which it might be brought, if any, which Employee has, might have, or might claim to have against
any of the Released Parties, for any and all injuries, harm, damages, wages, benefits, salary, reimbursements, penalties, costs, losses,
expenses, attorneys’ fees, and/or liability or other detriment, if any, whatsoever and whenever incurred, suffered, or claimed
by Employee.

 

5. Nothing
in this Agreement shall affect Employee’s right to file a charge of discrimination with the Equal Employment Opportunity Commission
(“EEOC”) or any other federal, state or local agency with similar responsibilities, and nothing in this Agreement
shall affect the EEOC’s rights and responsibilities to enforce any employment laws. However, by signing this Agreement, Employee
waives any right Employee may have to receive any money or other benefits arising from any such charge, and Employee specifically and
freely waives any and all claims regardless of whether Employee knows or suspects such claims exist at the time of executing this Agreement.
This Agreement does not release any claims of the specific type referenced in 26 U.S.C. § 162(q), which claims referenced in §
162(q) the Parties agree are not released by this Agreement and such claims Employee has not made against any of the Released Parties.
By executing this Agreement, Employee represents, warrants and affirms that Employee does not have any of the claims of the specific
type referenced in 26 U.S.C. § 162(q) against any of the Released Parties. This Agreement does not release Employee’s right
to the 9,036 vested shares of common stock of Company (“Vested Shares”), which Vested Shares are governed by the RSA
and the LTIP, as it may be amended from time to time.

 

6. Employee
acknowledges and agrees that Employee’s normal fringe benefits, excluding Employee’s health insurance coverage, terminated
on the Termination Date. Employee’s health insurance coverage will terminate December 31, 2022. Employee may be eligible for continued
health insurance coverage, at Employee’s option and expense, in conformity with the Consolidated Omnibus Budget Reconciliation
Act. Employee’s rights and benefits, if any, under any pension or retirement plan provided by Employer will be determined pursuant
to the terms of such plans.

 

7. Employee
agrees that this Agreement is confidential and that Employee will not discuss the fact that it exists or its terms (including, without
limitation, the amount of the Separation Payment) with anyone else except Employee’s attorney as described in Section 8 below,
Employee’s tax accountant, or as required by law. However, nothing in this Agreement shall prevent Employee from providing lawful
and truthful information to any agent of any federal, state, or local government or in response to any subpoena or other process.

 

    	2

    	 

    

 

8. Subject
to the last sentence of Section 7, Employee agrees not to disparage Employer or any of the Released Parties, in any manner likely to
be harmful to any of them or their business, business reputation, or personal reputation.

 

9. This
Agreement sets forth the entire Agreement between Employee and any of the Released Parties pertaining to the subject matter of this Agreement,
save and except for the RSA and Sections 9 and 13 through 31 of the Employment Agreement between the Parties with an Effective Date of
June 1, 2019 (the “Employment Agreement”). The Parties agree that the RSA and Sections 9 and 13 through 31 of the
Employment Agreement continue to be in effect and are not superseded by this Agreement. No oral understandings, statement, promises or
inducements contrary to the terms of this Agreement exist. The Parties represent and acknowledge that, in executing this Agreement, they
do not rely, and have not relied, on any representation(s) by Employee or any of the Released Parties, except as expressly contained
in this Agreement. Rather, they have relied on their own judgment.

 

10. Employee
acknowledges that Employee has returned to Employer any and all Employer property, as well as the originals and/or copies of documents
relating to the business of Employer or any of the other Released Parties, without altering or deleting any of the information, files
or data on the Employer property before it is returned to Employer (e.g., not deleting emails or files from any Employer laptop).

 

11. This
Agreement has been made in Texas, and Texas law applies to it, without regard to any conflict of law principles of any jurisdiction.
If any part of this Agreement is found to be invalid, the remaining parts of the Agreement will remain in effect as if there were no
invalid part. Venue for any action to enforce this Agreement shall exclusively be in Tarrant County, Texas. This Agreement may be executed
in any number of counterparts, each of which shall be deemed an original, but all of which together shall deemed one and the same instrument.

 

12. By
signing below, Employee understands and agrees that Employee has carefully read and fully understands all of the provisions of this Agreement.
The Parties represent that they have not transferred or assigned to any person or entity any claim related to this Agreement or any portion
thereof, or any interest therein. Employee represents, warrants and agrees that Employee has not as of the date that Employee signs this
Agreement filed any claim of any sort against any of the Released Parties.

 

13. Employee
acknowledges that Employee has had an opportunity to consult with an attorney concerning the meaning, import, and legal significance
of this Agreement, and has read this Agreement, as signified by Employee’s signature hereto, and is voluntarily executing this
Agreement.

 

14. By
signing below, Employee understands and agrees that Employee:

 

(a) HAS
CAREFULLY READ AND FULLY UNDERSTANDS ALL OF THE PROVISIONS OF THIS AGREEMENT;

 

(b) HAS
AT ALL TIMES DURING THE COURSE OF NEGOTIATION AND EXECUTION OF THIS AGREEMENT HAD THE OPPORTUNITY TO DISCUSS THOROUGHLY THIS AGREEMENT
WITH ANYONE THAT EMPLOYEE DESIRED, CONCERNING THE TERMS OF THIS AGREEMENT AND THAT EMPLOYEE IS HEREBY ADVISED IN WRITING TO CONSULT
WITH COUNSEL OF EMPLOYEE’S CHOICE PRIOR TO ENTERING INTO THIS AGREEMENT;

 

    	3

    	 

    

 

(c) IS,
THROUGH THIS AGREEMENT, RELEASING EMPLOYER, ALONG WITH THE OTHER PARTIES NAMED ABOVE AS THE “RELEASED PARTIES,” FROM ANY
AND ALL CLAIMS THAT EMPLOYEE HAS OR MAY HAVE AGAINST THEM, INCLUDING ANY CLAIM UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT;

 

(d) KNOWINGLY
AND VOLUNTARILY AGREES TO ALL OF THE TERMS SET FORTH IN THIS AGREEMENT;

 

(e) KNOWINGLY
AND VOLUNTARILY INTENDS TO BE LEGALLY BOUND BY THE SAME;

 

(f) WAIVES
RIGHTS OR CLAIMS IN EXCHANGE FOR the Separation Benefits ACCELERATION WHICH EMPLOYEE WOULD
NOT OTHERWISE RECEIVE; AND

 

(g) HAS
21 DAYS FROM THE DATE THIS AGREEMENT IS PROVIDED TO EMPLOYEE (“REVIEW PERIOD”) TO CONSIDER WHETHER OR NOT TO EXECUTE
THIS AGREEMENT, AND ADDITIONALLY HAS A FULL SEVEN (7) DAYS FOLLOWING THE EXECUTION OF THIS AGREEMENT BY EMPLOYEE (“REVOCATION
PERIOD”) TO REVOKE THIS AGREEMENT BY WRITTEN LETTER SENT BY HAND DELIVERY OR ELECTRONIC MAIL TO: ZACHARY FLEMING, 1200 SUMMIT
AVENUE, SUITE 414, FORT WORTH, TEXAS 76102, OR EMAIL: ZFLEMING@SANARAMEDTECH.COM. EMPLOYEE HAS BEEN AND IS HEREBY ADVISED IN WRITING
THAT THIS AGREEMENT SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED WITHOUT EMPLOYEE EXERCISING HIS
RIGHT TO REVOCATION. IF EMPLOYEE REVOKES THIS AGREEMENT, EMPLOYEE WILL NOT BE ENTITLED TO THE Separation
Benefits DESCRIBED IN SECTION 3 ABOVE. THE PARTIES AGREE THAT ANY CHANGES TO THIS AGREEMENT, WHETHER MATERIAL OR IMMATERIAL, WILL
NOT RESTART THE RUNNING OF THE REVIEW PERIOD.

 

	/s/
    Shawn M. Bowman	 	12/2/2022	 
	Shawn
    M. Bowman	 	Date	 

 

	SANARA MEDTECH INC.	 	 	 
	 	 	 	 	 
	/s/ Michael McNeil	 	12/2/2022	 
	By:
    	Michael
    McNeil	 	Date	 
	Title:
    	Chief
    Financial Officer	 	 	 

 

    	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]